and management remains challenging despite advances in therapeutic options. CS is
caused by severe impairment of myocardial performance that results in diminished cardiac …

OBJECTIVES: To review a contemporary approach to the management of patients with
cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding …

Despite efforts at early revascularization in acute coronary syndrome and advancing
technologies in the field of temporary mechanical circulatory support (TMCS), the mortality …

Aim: Evidence on non-ischemic cardiogenic shock (CS) is scarce. The aim of this study was
to investigate differences in patient characteristics, use of treatments and outcomes in …

Despite advances in percutaneous coronary interventions and their widespread use,
mortality in patients presenting with acute myocardial infarction (MI) complicated by …

Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of
morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in …

Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state
of end-organ hypoperfusion that is frequently associated with multisystem organ failure …

Background: Few studies describe recent changes in the incidence, treatment, and
outcomes of cardiogenic shock. Objective: To examine temporal trends in the incidence …

Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …